J. Armstrong

发表

Final report of the 70.2-Gy and 75.6-Gy dose levels of a phase I dose escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable non-small cell lung cancer.

C. Ling, K. Rosenzweig, M. Kris, 2000, Cancer journal.

SPAR – a randomised, placebo-controlled phase II trial of simvastatin in addition to standard chemotherapy and radiation in preoperative treatment for rectal cancer: an AGITG clinical trial

F. Frizelle, S. Ackland, C. Karapetis, 2019, BMC Cancer.

SPAR: A randomized placebo-controlled phase 2 trial of simvastatin in addition to standard chemotherapy and radiation in preoperative treatment for rectal cancer: An AGITG clinical trial.

F. Frizelle, S. Ackland, C. Karapetis, 2022, Journal of Clinical Oncology.